BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33539440)

  • 1. Higher plasma drug levels in elderly people living with HIV treated with darunavir.
    Tyrberg E; Edén A; Eriksen J; Nilsson S; Treutiger CJ; Thalme A; Mellgren Å; Gisslén M; Andersson LM
    PLoS One; 2021; 16(2):e0246171. PubMed ID: 33539440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body weight and blood pressure changes on dolutegravir-, efavirenz- or atazanavir-based antiretroviral therapy in Zimbabwe: a longitudinal study.
    Shamu T; Egger M; Mudzviti T; Chimbetete C; Manasa J; Anderegg N
    J Int AIDS Soc; 2024 Feb; 27(2):e26216. PubMed ID: 38332525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efavirenz but Not Atazanavir/Ritonavir Significantly Reduces Atovaquone Concentrations in HIV-Infected Subjects.
    Calderón MM; Penzak SR; Pau AK; Kumar P; McManus M; Alfaro RM; Kovacs JA
    Clin Infect Dis; 2016 Apr; 62(8):1036-1042. PubMed ID: 26797214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Lipidomic Signatures in People Living With HIV: Combined Analysis of ACTG 5260s and MACS/WIHS.
    Jao J; Balmert LC; Sun S; McComsey GA; Brown TT; Tien PC; Currier JS; Stein JH; Qiu Y; LeRoith D; Kurland IJ
    J Clin Endocrinol Metab; 2022 Jan; 107(1):119-135. PubMed ID: 34498048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of efavirenz and 8-hydroxy-efavirenz plasma levels on cognition and central nervous system side effects.
    Ranzani A; Castelli F; Di Biagio A; d'Arminio Monforte A; D'Avolio A; Soria A; Bai F; Focà E; Taramasso L; Calcagno A; Bresciani E; Torsello A; Bonfanti P; Lapadula G
    HIV Med; 2024 Apr; 25(4):491-497. PubMed ID: 38104964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic spine injury induced by the 8-hydroxy metabolite of efavirenz.
    Tovar-y-Romo LB; Bumpus NN; Pomerantz D; Avery LB; Sacktor N; McArthur JC; Haughey NJ
    J Pharmacol Exp Ther; 2012 Dec; 343(3):696-703. PubMed ID: 22984227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Concentrations of Rosmarinic Acid in Patients on Antiretroviral Therapy: In Silico Exploration Based on Clinical Data.
    Hitl M; Pavlović N; Brkić S; Dragović G; Srđenović-Čonić B; Kladar N
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics and COVID-19: clinical implications of human genome interactions with repurposed drugs.
    Badary OA
    Pharmacogenomics J; 2021 Jun; 21(3):275-284. PubMed ID: 33542445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial.
    Maertens JA; Rahav G; Lee DG; Ponce-de-León A; Ramírez Sánchez IC; Klimko N; Sonet A; Haider S; Diego Vélez J; Raad I; Koh LP; Karthaus M; Zhou J; Ben-Ami R; Motyl MR; Han S; Grandhi A; Waskin H;
    Lancet; 2021 Feb; 397(10273):499-509. PubMed ID: 33549194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of postpartum tenofovir-based antiretroviral therapy on bone mineral density in breastfeeding women with HIV enrolled in a randomized clinical trial.
    Stranix-Chibanda L; Tierney C; Sebikari D; Aizire J; Dadabhai S; Zanga A; Mukwasi-Kahari C; Vhembo T; Violari A; Theron G; Moodley D; George K; Fan B; Sommer MJ; Browning R; Mofenson LM; Shepherd J; Nelson B; Fowler MG; Siberry GK;
    PLoS One; 2021; 16(2):e0246272. PubMed ID: 33544759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief Report: Improvement in Metabolic Health Parameters at Week 48 After Switching From a Tenofovir Alafenamide-Based 3- or 4-Drug Regimen to the 2-Drug Regimen of Dolutegravir/Lamivudine: The TANGO Study.
    van Wyk J; Ait-Khaled M; Santos J; Scholten S; Wohlfeiler M; Ajana F; Jones B; Nascimento MC; Tenorio AR; Smith DE; Wright J; Wynne B
    J Acquir Immune Defic Syndr; 2021 Jun; 87(2):794-800. PubMed ID: 33587500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Group A
    Khademi F; Vaez H; Sahebkar A; Taheri RA
    Oman Med J; 2021 Jan; 36(1):e222. PubMed ID: 33585043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Untimed Efavirenz Drug Levels After Switching From Brand to Generic Formulations: A Short Communication.
    Watson BE; Atkinson K; Auyeung K; Baynes KA; Lepik KJ; Toy J; Sereda P; Barrios R; Brumme CJ
    Ther Drug Monit; 2021 Oct; 43(5):701-705. PubMed ID: 33560098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wipe-sampling procedure optimisation for the determination of 23 antineoplastic drugs used in the hospital pharmacy.
    Guichard N; Boccard J; Rudaz S; Bonnabry P; Fleury Souverain S
    Eur J Hosp Pharm; 2021 Mar; 28(2):94-99. PubMed ID: 33608437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous Toxicities in Breast Cancer Patients Receiving Chemotherapy and Targeted Agents--An Observational Clinical Study.
    Anoop TM; Joseph P R; Pn M; Kp P; Gopan G; Chacko S
    Clin Breast Cancer; 2021 Aug; 21(4):e434-e447. PubMed ID: 33608219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and prognostic factors of critically ill patients with COVID-19 in Daegu, South Korea: A multi-center retrospective study.
    Kim EJ; Lee YH; Park JS; Lee J; Lee SY; Kim Y; Kwon YS; Jang JG; Shin KC; Kim KC; Choi EY
    Medicine (Baltimore); 2021 Feb; 100(7):e24437. PubMed ID: 33607776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decision Analysis: Omadacycline Relative to Moxifloxacin Among Hospitalized Community-Acquired Bacterial Pneumonia Patients at Risk of Clostridioides difficile Infection.
    Lodise TP; Mistry R; Young K; LaPensee K
    Clin Drug Investig; 2021 Mar; 41(3):269-275. PubMed ID: 33604769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends of Antimicrobial Resistance in Typhoidal Strains of Salmonella in a Tertiary Care Hospital in Pakistan.
    Aslam A; Ahmed Kharal S; Aslam M; Raza A
    Cureus; 2021 Jan; 13(1):e12664. PubMed ID: 33604204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of gyrA and parC Mutations and Prevalence of Plasmid-Mediated Quinolone Resistance Genes in
    Kareem SM; Al-Kadmy IMS; Kazaal SS; Mohammed Ali AN; Aziz SN; Makharita RR; Algammal AM; Al-Rejaie S; Behl T; Batiha GE; El-Mokhtar MA; Hetta HF
    Infect Drug Resist; 2021; 14():555-563. PubMed ID: 33603418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic use Evaluation in Hospitalized Pediatric Patients with Respiratory Tract Infections: A Retrospective Chart Review Study.
    Mahboobipour AA; Baniasadi S; Shahrebabaki ES; Tashayoie-Nejad S; Hassanzad M
    Curr Drug Saf; 2022; 17(1):17-23. PubMed ID: 33602106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.